KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to 0.49.

  • Supernus Pharmaceuticals' Asset Utilization Ratio fell 0.82% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year decrease of 0.82%. This contributed to the annual value of 0.50 for FY2024, which is 22.71% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Asset Utilization Ratio stood at 0.49, which was down 0.18% from 0.49 recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.49 in Q1 2025 and a low of 0.36 during Q4 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.47, with a median of 0.48 in 2024.
  • In the last 5 years, Supernus Pharmaceuticals' Asset Utilization Ratio dropped by 2.21% in 2022 and then increased by 21.75% in 2023.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Asset Utilization Ratio stood at 0.36 in 2021, then rose by 9.95% to 0.39 in 2022, then grew by 20.64% to 0.47 in 2023, then increased by 2.99% to 0.49 in 2024, then decreased by 0.82% to 0.49 in 2025.
  • Its Asset Utilization Ratio stands at 0.49 for Q3 2025, versus 0.49 for Q2 2025 and 0.49 for Q1 2025.